Detalhe da pesquisa
1.
BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study.
Cancer
; 127(8): 1246-1259, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270904
2.
DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity.
J Exp Clin Cancer Res
; 41(1): 97, 2022 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35287686
3.
Aleglitazar, a balanced PPARα/γ agonist, has no clinically relevant pharmacokinetic interaction with high-dose atorvastatin or rosuvastatin.
Expert Opin Investig Drugs
; 20(1): 3-12, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21114416
4.
Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing.
J Cell Sci
; 115(Pt 7): 1383-9, 2002 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11896186